It is suggested that despite the phenomenological similarity between cataleptic states of different origin (pinch-induced, “audiogenic”) their neurophysiologic substrates overlap only partially. The findings are considered as presenting genetic model for further analysis of catalepsy.”
“There has been a good deal of research on the role of anxiety sensitivity in pain perception, but only recently have investigators begun to assess its role in labor pain. The aim of this study was to investigate the nature of this relationship as well as the relationship
of state and trait anxiety with labor pain. Assessments of maximum and average labor pain were completed in three SRT2104 in vitro different time periods (before, during and immediately after labor, and 1 month postpartum). Anxiety and anxiety sensitivity measures were completed during the late stage of pregnancy. A total of 46 primiparous healthy pregnant women, carrying a single child, participated in the study. State
anxiety correlated significantly with maximum (r = 0.352, p < 0.01) and average (r = 0.325, p < 0.05) labor pain expectancies, whereas trait anxiety correlated significantly with maximum labor pain expectancies (r = 0.306, p < 0.05). During labor, only the physical concerns dimension of anxiety sensitivity shared a significant relationship with sensory pain (r = 0.292, p < 0.05). In www.selleckchem.com/products/gdc-0032.html conclusion, anxiety shares a significant relationship with labor pain expectancies only, whereas the physical concerns dimension of anxiety sensitivity correlates significantly with sensory pain during labor. These data clarify the role of anxiety and anxiety sensitivity in the experience NVP-HSP990 inhibitor of labor pain. Clinical implications are discussed.”
“Recent studies have reported that a novel cardiac biomarker, heart-type fatty acid-binding protein (h-FABP), significantly predicts mortality inpatients with pulmonary embolism (PE)
at intermediate risk. The aim of this study was to evaluate the effect of thrombolytic therapy on prognosis of the intermediate risk acute PE patients with elevated levels of h-FABP. This is non-interventional, prospective, and single-center cohort study where 80 patients (mean age 62 +/- A 17 years, 32 men) with confirmed acute PE were included. Only patients with PE at intermediate risk (echocardiographic signs of right ventricular overload but without evidence for hypotension or shock) were included in the study. h-FABP and other biomarkers were measured upon admission to the emergency department. Thrombolytic (Thrl) therapy was administered at the physician’s discretion. Of the included 80 patients, 24 were h-FABP positive (30 %). 14 patients (58 %) with positive h-FABP had clinical deterioration during the hospital course and required inotropic support and 12 of these patients died.